
|Articles|April 27, 2018
Controversies in Urologic Cancer
How can you be sure you’ve selected the best approach for your patients with urologic cancer? As our experts debate developments like MRI fusion biopsy for PCa, HIFU for low-risk prostate cancer, and white light cystoscopy, learn how you can integrate these treatments into your practice.
Advertisement
Having trouble viewing?
Once you access the file, position your mouse over the top middle for a toolbar:
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
2
Cooled laser focal therapy shows promise for localized prostate cancer
3
John Sfakianos, MD, on dual immune checkpoint inhibition in NMIBC
4
Annual ACS NCDB report details national trends in prostate cancer care
5

